CN116322658B - 含罗匹尼罗的贴附剂及罗匹尼罗的皮肤透过性的提升方法 - Google Patents
含罗匹尼罗的贴附剂及罗匹尼罗的皮肤透过性的提升方法Info
- Publication number
- CN116322658B CN116322658B CN202180067163.XA CN202180067163A CN116322658B CN 116322658 B CN116322658 B CN 116322658B CN 202180067163 A CN202180067163 A CN 202180067163A CN 116322658 B CN116322658 B CN 116322658B
- Authority
- CN
- China
- Prior art keywords
- ropinirole
- adhesive
- adhesive layer
- sodium
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020-181280 | 2020-10-29 | ||
| JP2020181280 | 2020-10-29 | ||
| PCT/JP2021/038892 WO2022091925A1 (ja) | 2020-10-29 | 2021-10-21 | ロピニロール含有貼付剤及びロピニロールの皮膚透過性向上方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116322658A CN116322658A (zh) | 2023-06-23 |
| CN116322658B true CN116322658B (zh) | 2025-09-26 |
Family
ID=81382322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180067163.XA Active CN116322658B (zh) | 2020-10-29 | 2021-10-21 | 含罗匹尼罗的贴附剂及罗匹尼罗的皮肤透过性的提升方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12440452B2 (enExample) |
| EP (1) | EP4238563B1 (enExample) |
| JP (1) | JP7284877B2 (enExample) |
| KR (1) | KR102577838B1 (enExample) |
| CN (1) | CN116322658B (enExample) |
| TW (1) | TWI821765B (enExample) |
| WO (1) | WO2022091925A1 (enExample) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110300582A (zh) * | 2017-02-24 | 2019-10-01 | 久光制药株式会社 | 贴附剂及其包装体 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5872111A (en) * | 1997-05-19 | 1999-02-16 | Lever Brothers Company, Division Of Conopco, Inc. | Compositions comprising glycosylamide surfactants |
| DE10137162A1 (de) * | 2001-07-30 | 2003-02-20 | Hexal Ag | Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol |
| JP5546013B2 (ja) * | 2008-02-27 | 2014-07-09 | 久光製薬株式会社 | 貼付剤及び包装体 |
| US20110028880A1 (en) | 2008-02-27 | 2011-02-03 | Hisamitsu Pharmaceutical Co., Inc. | Patch |
| ES2513691T3 (es) | 2009-05-21 | 2014-10-27 | Hisamitsu Pharmaceutical Co., Inc. | Preparación transdérmica |
| JP5631854B2 (ja) | 2010-12-13 | 2014-11-26 | 久光製薬株式会社 | 医薬組成物および貼付剤 |
| JPWO2012165254A1 (ja) | 2011-05-31 | 2015-02-23 | 久光製薬株式会社 | ロピニロール含有貼付剤及びその包装体 |
| ES2641651T3 (es) * | 2011-05-31 | 2017-11-10 | Hisamitsu Pharmaceutical Co., Inc. | Parche que contiene ropinirol y envase para el mismo |
| JP6104173B2 (ja) | 2011-12-01 | 2017-03-29 | 帝國製薬株式会社 | ロピニロール含有貼付剤 |
| CN104736176B (zh) * | 2012-08-24 | 2017-10-13 | 英特格拉斯疗法有限公司 | 用于增强治疗剂透皮递送的化学组合物和方法 |
| TWI709417B (zh) * | 2013-10-07 | 2020-11-11 | 美商帝國製藥美國股份有限公司 | 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物 |
| WO2015066647A2 (en) | 2013-11-03 | 2015-05-07 | The Regents Of The University Of California | Ionic liquids for transdermal drug delivery |
| JP6373061B2 (ja) | 2014-05-23 | 2018-08-15 | 帝國製薬株式会社 | 経皮投与製剤 |
| WO2017037812A1 (ja) | 2015-08-29 | 2017-03-09 | 株式会社メドレックス | 酸捕捉剤を含有する貼付製剤 |
| JP6865743B2 (ja) * | 2015-10-01 | 2021-04-28 | フィルメニッヒ インコーポレイテッドFirmenich Incorporated | Trpm8の活性調節因子として有用な化合物 |
| TWI825013B (zh) * | 2017-04-19 | 2023-12-11 | 日商帝國製藥股份有限公司 | 含有盧帕他定(rupatadine)之貼附劑 |
| CN107375249A (zh) * | 2017-07-26 | 2017-11-24 | 徐静 | 一种含罗匹尼罗的缓释透皮贴剂及其应用 |
| EP3700511A1 (en) * | 2017-10-17 | 2020-09-02 | Lubrizol Advanced Materials, Inc. | Composition and device for delivery of active agents to skin surfaces |
-
2021
- 2021-10-21 CN CN202180067163.XA patent/CN116322658B/zh active Active
- 2021-10-21 US US18/034,480 patent/US12440452B2/en active Active
- 2021-10-21 JP JP2022559066A patent/JP7284877B2/ja active Active
- 2021-10-21 EP EP21886044.3A patent/EP4238563B1/en active Active
- 2021-10-21 KR KR1020237016598A patent/KR102577838B1/ko active Active
- 2021-10-21 WO PCT/JP2021/038892 patent/WO2022091925A1/ja not_active Ceased
- 2021-10-28 TW TW110140142A patent/TWI821765B/zh active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110300582A (zh) * | 2017-02-24 | 2019-10-01 | 久光制药株式会社 | 贴附剂及其包装体 |
Also Published As
| Publication number | Publication date |
|---|---|
| KR102577838B1 (ko) | 2023-09-12 |
| CN116322658A (zh) | 2023-06-23 |
| TW202227052A (zh) | 2022-07-16 |
| TWI821765B (zh) | 2023-11-11 |
| JPWO2022091925A1 (enExample) | 2022-05-05 |
| EP4238563A4 (en) | 2024-10-02 |
| WO2022091925A1 (ja) | 2022-05-05 |
| JP7284877B2 (ja) | 2023-05-31 |
| EP4238563A1 (en) | 2023-09-06 |
| EP4238563B1 (en) | 2025-09-24 |
| KR20230088789A (ko) | 2023-06-20 |
| US20240016758A1 (en) | 2024-01-18 |
| US12440452B2 (en) | 2025-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6689443B2 (ja) | 貼付剤及びその包装体 | |
| WO2018198925A1 (ja) | 貼付剤 | |
| TWI775149B (zh) | 含羅匹尼羅之貼附劑及羅匹尼羅之皮膚透過性之提升方法 | |
| CN116322658B (zh) | 含罗匹尼罗的贴附剂及罗匹尼罗的皮肤透过性的提升方法 | |
| CN110545816B (zh) | 贴附剂 | |
| CN114727986B (zh) | 含罗匹尼罗的贴附剂的粘合剂层保持力提升方法及含罗匹尼罗的保持力改善的贴附剂 | |
| CN120282781A (zh) | 含有罗替戈汀的贴附剂及罗替戈汀稳定性提升方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |